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ABSTRACT: A non-specific exopeptidase, 
aminopeptidase N (APN), is inhibited sequence 
specifically by a synthetic host, cucurbit[7]uril (Q7), 
which binds with high affinity and specificity to N-
terminal phenylalanine (Phe) or 4-aminomethyl 
phenylalanine (AMPhe) and prevents their 
removal from the peptide. Liquid chromatography 
experiments demonstrate that in the presence of 
excess Q7, APN quantitatively converts the 
pentapeptides Thr-Gly-Ala-X-Met into the 
dipeptides X-Met (X = Phe or AMPhe). The 
resulting Q7-bound products are completely stable 
to proteolytic digestion for at least 24 h. Structure-
activity studies reveal a direct correlation between 
the extent of protection of an N-terminal amino 
acid and its affinity for Q7. Therefore, Q7 provides 
predictable sequence specificity to an otherwise 
non-specific protease and enables the production of 
a single peptide product. Conversely, APN 
uncovers a high-affinity epitope, which is then 
bound by Q7, and thus this approach should also 
facilitate the molecular recognition of peptides. 
Methods for selective enzymatic digestion of 
peptides and proteins are crucial to many 
processes in molecular biology and biotechnology. 
Proteases are used widely to process polypeptides 
for sequencing1 and other applications in 
proteomics2 and medicine.3 Endopeptidases, which 
cleave the peptide backbone at nonterminal sites, 
typically have well-defined sequence specificity. 
Exopeptidases, which remove amino acids 
sequentially from a terminus, can be specific for a 
small set of amino acids or generally non-specific, 
which allows them to digest a peptide completely 
into amino acids.4,5 Developing methods that 
change the substrate specificity of proteases would 
broaden the scope of their applications. Here we 
show that a synthetic receptor, cucurbit[7]uril (Q7), 
can be used to impart specificity to an otherwise 
non-specific exopeptidase, porcine aminopeptidase 
N (APN), by binding to a specific residue and 
inhibiting its removal from the peptide. 
Q7 is a highly stable container molecule that 
can associate noncovalently with a wide range of 
cationic organic guests in aqueous media with 
equilibrium association constant (Ka) values of up 
to 1015 M-1.6-8 We and others have studied the 
capacity of Q7 to bind to amino acids, peptides, 
and proteins and found that Q7 prefers to bind N-
terminal phenylalanine (Phe), tyrosine (Tyr), and 
tryptophan (Trp) residues, by incorporating the 
sidechain within the nonpolar Q7 cavity and 
chelating the N-terminal ammonium group with 
Q7 carbonyl oxygens.9-14 Nau and coworkers have 
shown that Q7 can slow the activity of an 
endopeptidase, trypsin, and an exopeptidase, 
leucine aminopeptidase (LAP), by binding to their 
respective substrates.15,16 In both cases, they 
observed only partial and short-lived inhibition. 
We hypothesized that this approach could be used 
to crop a complete sample of peptide down to the 
first Phe residue if the aminopeptidase could be 
inhibited exclusively at this position. 
LAP was not completely inhibited by Q7,15,16 
and thus we wanted to test a different 
aminopeptidase. APN was chosen for its lack of 
specificity,4 its medicinal relevance,17 and its 
commercial availability. The pentapeptide, Thr-
Gly-Ala-Phe-Met (1), was chosen as the first 
substrate for APN digestion because it contains five 
different amino acid residues, including hydro-
philic and hydrophobic sidechains, and it contains 
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Figure 1. (left) Schematic illustration of the inhibition 
of APN-mediated peptide digestion at a Phe residue 
using Q7. (right) Chemical formula of Q7 and sche-
matic of the molecular recognition of N-terminal Phe. 
a non-terminal Phe residue, which becomes the N-
terminal residue after APN removes the Thr, Gly, 
and Ala residues (Figure 1). The entrance to the 
catalytic site of APN is highly constricted, and 
specific interactions are made with the sidechain of 
the terminal residue.18 Q7 should protect an N-
terminal Phe by encapsulating its sidechain and 
interacting directly with the terminal ammonium 
group (Figure 1). Peptide 1 and the predicted 
product of digestion, Phe-Met (2), were 
synthesized. These peptides and the others used in 
this study have C-terminal amides because they 
were synthesized on Rink amide resin. 
Analytical HPLC was used to monitor the 
digestion of 0.50 mM peptide 1 by 0.20 M APN in 
the absence of Q7 and in the presence of a 
substoichiometric quantity (0.25 mM), a 
stoichiometric quantity (0.50 mM), and a 2-fold 
excess (1.0 mM) of Q7 (Figure 2). Samples were 
analyzed at reaction times of 5 min, 3 h, and 24 h. 
At the 5 min time point, we observed substantial 
degradation of the starting material (retention time 
21-22 min) in the absence of Q7 and at 0.25 mM Q7, 
and substantially slower degradation with 0.50 mM 
and 1.0 mM Q7. 
At the 3 h time point (Figure 2b), all samples 
showed complete disappearance of starting 
material. Remarkably, only one peak (at ~6 min) 
remained in the HPLC traces of the samples 
containing 0.50 mM and 1.0 mM Q7. The broad 
shape and retention time of these peaks correspond 
exactly to those of a standard sample of the Q7•2 
complex, and electrospray ionization mass spectro-
metry (ESI-MS) confirmed the digestion product as 
 
Figure 2. Analytical HPLC traces of the digestion of 
0.5 mM Thr-Gly-Ala-Phe-Met (1) with 0.20 M APN 
in the presence of 0, 0.5, 1.0, or 2.0 molar equivalents 
of Q7 at 37 C in 10 mM ammonium phosphate, pH 
7.2. Reaction times are (a) 5 min, (b) 3 h, and (c) 24 h. 
the Q7•2 complex (see Supporting Information). 
The conversion of pentapeptide 1 to the Q7•2 
complex was quantified by comparing the area of 
the product peak with that of a standard sample of 
Q7•2. We observed quantitative conversion (101% 
±1.1% and 98% ±1.3%) in the presence of 1.0 mM 
Q7 and 0.50 mM Q7, respectively. With 
substoichiometric Q7 (0 or 0.25 mM), however, 
there was no substantial formation of the Q7•2 
product. Instead, we observed a peak at ~4 min that 
corresponds to the free Phe amino acid. 
At the 24 h time point (Figure 2c), there was no 
change in the HPLC trace of the sample containing 
1.0 mM Q7. This result indicates that the Q7•2 
complex is highly stable under these conditions. In 
the sample containing 0.5 mM Q7, we observed a 
37% reduction in the area of the Q7•2 peak.19 
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Therefore, an excess of Q7 is needed to protect the 
Q7•2 product over longer periods of time. 
 
Table 1. Peptide Protection vs. the Binding Constant. 
Peptide 
    Residual  
  Peptide (%) 
        Ka (M-1) c 
Phe-Met (2) 
Phe-Met (2) 
Tyr-Met (3) 
Trp-Met-Gly (4) 
AMPhe-Met (5) 
  93.9 (±1.1)a 
100.4 (±1.4)b 
  19.8 (±3.5)a 
    1.5 (±0.1)a 
101.6 (±1.5)a 
   1.4 (±0.1) x 107 
    
   6.4 (±0.4) x 105 
   2.3 (±0.1) x 105 
   5.3 (±1.1) x 108 
a Fraction of 0.50 mM peptide that remains after 24 
h in the presence of 1.0 mM Q7, 0.20 M APN. b Frac-
tion of 0.10 Phe-Met that remains after 24 h in the 
presence of 1.0 mM Q7, 0.040 M APN.  All experi-
ments were performed at 37 C in 10 mM ammonium 
phosphate, pH 7.2, and values were determined by 
integrated peak intensities in the HPLC traces of 
samples after 24 h. c Mean values measured from at 
least three ITC experiments at 27 C in 10 mM ammo-
nium phosphate, pH 7.2. Standard deviations are giv-
en in parentheses. 
It is interesting to consider how the increased 
concentrations of Q7 impeded initial degradation 
of the substrate at the 5 min time point. In the 
samples containing 0.50 mM and 1.0 mM Q7, 
appreciable quantities of the Q7•2 complex had not 
yet formed, but enzymatic activity was clearly 
retarded. Higher Q7:1 ratios were needed to form 
and protect the Q7•2 product at 3 h and 24 h. 
These results suggest that Q7 also has a small 
inhibitory effect by binding to the enzyme but that 
inhibition of proteolysis is primarily governed by 
binding to the substrate, as observed for LAP.15 
The highest affinity binding sites for Q7 on 
natural peptides are at N-terminal Phe, Tyr, and 
Trp residues (Ka ~105-107 M-1); other potential 
binding sites have much weaker affinities.9 In order 
to assess the extent to which Q7 can protect these 
residues from APN digestion, we prepared a series 
of peptides with different aromatic N-termini and 
measured the extent of their protection by Q7 in 
the presence of APN. Phe-Met (2), Tyr-Met (3), and 
Trp-Met-Gly (4), each at 0.50 mM, were incubated 
for 24 h with 1.0 mM Q7 and 0.20 M APN and 
then analyzed by HPLC. Table 1 gives the residual 
quantities of peptides that remain after 24 h and 
compares these values to their binding affinities for 
Q7, as determined by isothermal titration 
calorimetry (ITC). These data reveal a direct 
correlation between binding affinity and extent of 
protection by Q7, and they demonstrate that Q7  
 
Figure 3. Analytical HPLC traces of the reaction of 0.5 
mM Thr-Gly-Ala-AMPhe-Met (6) with 0.20 M in the 
presence of 0.83 mM Q7 at 37 C in 10 mM ammoni-
um phosphate, pH 7.2. 
inhibits APN degradation most effectively at a Phe 
residue. Given the clear substrate-inhibition 
mechanism, we should be able to increase the ratio 
of Q7:2 in order to increase the extent of protection 
by Q7. To test this hypothesis, we increased the 
ratio of Q7:2 to 10:1 and, in fact, observed complete 
retention of peptide 2 after 24 h (Table 1). 
Considering the correlation between the extent 
of peptide protection and its binding affinity to Q7, 
we were interested in examining a stronger binding 
site. N-terminal Phe is the preferred epitope in 
native peptides, but we found recently that Q7 can 
bind with nanomolar affinity to peptides containing 
a 4-aminomethyl phenylalanine (AMPhe) residue 
at the N-terminal position (Figure 3).20 Indeed, we 
observed quantitative protection of AMPhe-Met (5) 
(Ka = 5.3 x 108 M-1) from APN digestion in the 
presence of two equivalents of Q7 (Table 1).  
Given the strong protection of AMPhe-Met (5) 
by Q7, we wanted to test the ability of Q7 to inhibit 
the complete digestion of a peptide containing a 
non-terminal AMPhe residue. Therefore, we 
synthesized the pentapeptide Thr-Gly-Ala-AMPhe-
Met (6) and followed its degradation by APN using 
analytical HPLC (Figure 3). We observed 
substantial retention of starting material until at 
least 3 h, with complete disappearance of starting 
material by 16 h. Up to 3h, three new peaks in the 
 4 
2-5 min range grew, but at 16 h only a single peak 
remained (at ~4 min). This remaining peak 
correlates exactly with a standard sample of the 
Q7•5 complex and was confirmed to be the Q7•5 
complex by ESI-MS (see Supporting Information). 
In the absence of Q7, the peptide was digested 
completely into amino acids. 
These results demonstrate that Q7 can 
completely inhibit the removal of Phe and AMPhe 
residues from the N-terminal position of peptides 
by APN. In doing so, a peptide containing an 
internal Phe or AMPhe is cropped down to that 
residue. Therefore, Q7 imparts predictable 
sequence-specificity to an otherwise non-specific 
exopeptidase and enables the production of a 
single peptide product. This constitutes a novel 
approach to peptide processing that is specific, 
quantitative, and effective under mild conditions 
(pH 7.2 buffer, 37 C). Proteolysis is inhibited only 
when APN has reached a target residue. 
Conversely, if APN is inhibited, then a rare high-
affinity epitope (e.g., the N-terminal Phe) has been 
uncovered, and the resulting peptide product is 
bound by Q7. Therefore, this method may also 
facilitate the recognition and labeling of peptides at 
a single site.12,21-24 It remains to be seen whether the 
method will work with longer polypeptides or 
with other receptor/protease pairs.  Work in this 
area is ongoing and will be reported in due course. 
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